Veru Future Growth
Future criteria checks 2/6
Veru's earnings are forecast to decline at 9% per annum while its annual revenue is expected to grow at 27.5% per year. EPS is expected to grow by 0.9% per annum.
Key information
-9.0%
Earnings growth rate
0.9%
EPS growth rate
Personal Products earnings growth | 23.7% |
Revenue growth rate | 27.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 Aug 2024 |
Recent future growth updates
Recent updates
Is Veru (NASDAQ:VERU) A Risky Investment?
Aug 07What Veru Inc.'s (NASDAQ:VERU) 28% Share Price Gain Is Not Telling You
Jul 17Veru Inc.'s (NASDAQ:VERU) 35% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
May 31The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%
Jan 09Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)
Aug 16Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors
Apr 17Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price
Feb 14Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?
Jan 13Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically
Nov 13Veru Inc.: Safer Bet Is To Wait For The AdComm Verdict
Oct 17Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?
Sep 26Veru FDA AdCom meeting for COVID-19 therapy postponed
Sep 19Veru: A Good Combination Of A Stable Business And Growth Opportunities
Sep 13Veru surges 11% as FDA sets AdCom meeting to review COVID-19 therapy
Sep 07Veru sheds 13% to end rally as director sells shares
Aug 18Veru Q3 2022 Earnings Preview
Aug 10Veru updated analysis on COVID treatment sabizabulin will lead to EUA - Oppenheimer
Aug 03Veru eligible for expedited review in U.K. for COVID-19 therapy
Jul 25Veru: The Signs Seem To Point To An EUA For Sabizabulin
Jul 13Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2026 | 10 | -72 | -67 | -45 | 4 |
9/30/2025 | 13 | -49 | -55 | -34 | 5 |
9/30/2024 | 14 | -40 | -12 | -22 | 5 |
6/30/2024 | 14 | -37 | -27 | -27 | N/A |
3/31/2024 | 13 | -39 | -40 | -40 | N/A |
12/31/2023 | 16 | -63 | -60 | -60 | N/A |
9/30/2023 | 16 | -93 | -89 | -88 | N/A |
6/30/2023 | 15 | -126 | -100 | -99 | N/A |
3/31/2023 | 21 | -136 | -96 | -95 | N/A |
12/31/2022 | 28 | -116 | -74 | -73 | N/A |
9/30/2022 | 39 | -84 | -48 | -48 | N/A |
6/30/2022 | 52 | -47 | -28 | -27 | N/A |
3/31/2022 | 60 | -28 | -27 | -26 | N/A |
12/31/2021 | 61 | -16 | -26 | -25 | N/A |
9/30/2021 | 61 | 7 | -16 | -16 | N/A |
6/30/2021 | 57 | 0 | -15 | -15 | N/A |
3/31/2021 | 50 | 0 | 1 | 1 | N/A |
12/31/2020 | 47 | 2 | 1 | 1 | N/A |
9/30/2020 | 43 | -19 | -2 | -2 | N/A |
6/30/2020 | 40 | -10 | -3 | -3 | N/A |
3/31/2020 | 39 | -10 | -7 | -6 | N/A |
12/31/2019 | 36 | -13 | -7 | -6 | N/A |
9/30/2019 | 32 | -12 | -6 | -5 | N/A |
6/30/2019 | 28 | -17 | -7 | -7 | N/A |
3/31/2019 | 24 | -22 | -11 | -11 | N/A |
12/31/2018 | 20 | -22 | -13 | -13 | N/A |
9/30/2018 | 16 | -24 | -12 | -12 | N/A |
6/30/2018 | 14 | -21 | -8 | -8 | N/A |
3/31/2018 | 13 | -14 | N/A | -2 | N/A |
12/31/2017 | 13 | -11 | N/A | 0 | N/A |
9/30/2017 | 14 | -9 | N/A | 1 | N/A |
6/30/2017 | 14 | -6 | N/A | 0 | N/A |
3/31/2017 | 15 | -4 | N/A | -1 | N/A |
12/31/2016 | 17 | -3 | N/A | 0 | N/A |
9/30/2016 | 22 | 0 | N/A | -2 | N/A |
6/30/2016 | 26 | 3 | N/A | 1 | N/A |
3/31/2016 | 28 | 3 | N/A | 0 | N/A |
12/31/2015 | 34 | 5 | N/A | -1 | N/A |
9/30/2015 | 33 | 4 | N/A | -2 | N/A |
6/30/2015 | 31 | 3 | N/A | -1 | N/A |
3/31/2015 | 31 | 3 | N/A | 0 | N/A |
12/31/2014 | 24 | 2 | N/A | 1 | N/A |
9/30/2014 | 24 | 2 | N/A | 4 | N/A |
6/30/2014 | 24 | 10 | N/A | 1 | N/A |
3/31/2014 | 23 | 9 | N/A | 8 | N/A |
12/31/2013 | 28 | 12 | N/A | 12 | N/A |
9/30/2013 | 31 | 14 | N/A | 12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VERU is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VERU is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VERU is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VERU's revenue (27.5% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: VERU's revenue (27.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VERU's Return on Equity is forecast to be high in 3 years time